184 related articles for article (PubMed ID: 18370319)
1. The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigens.
Ehrlich JR; Tang L; Caiazzo RJ; Cramer DW; Ng SK; Ng SW; Liu BC
Methods Mol Biol; 2008; 441():175-92. PubMed ID: 18370319
[TBL] [Abstract][Full Text] [Related]
2. The 'reverse capture' autoantibody microarray: a native antigen-based platform for autoantibody profiling.
Ehrlich JR; Qin S; Liu BC
Nat Protoc; 2006; 1(1):452-60. PubMed ID: 17406268
[TBL] [Abstract][Full Text] [Related]
3. Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling.
Qin S; Qiu W; Ehrlich JR; Ferdinand AS; Richie JP; O'leary MP; Lee ML; Liu BC
Proteomics; 2006 May; 6(10):3199-209. PubMed ID: 16596707
[TBL] [Abstract][Full Text] [Related]
4. Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.
Gagnon A; Kim JH; Schorge JO; Ye B; Liu B; Hasselblatt K; Welch WR; Bandera CA; Mok SC
Clin Cancer Res; 2008 Feb; 14(3):764-71. PubMed ID: 18245537
[TBL] [Abstract][Full Text] [Related]
5. Native antigen fractionation protein microarrays for biomarker discovery.
Caiazzo RJ; O'Rourke DJ; Barder TJ; Nelson BP; Liu BC
Methods Mol Biol; 2011; 723():129-48. PubMed ID: 21370063
[TBL] [Abstract][Full Text] [Related]
6. A native antigen "reverse capture" microarray platform for autoantibody profiling of prostate cancer sera.
Ehrlich JR; Caiazzo RJ; Qiu W; Tassinari OW; O'Leary MP; Richie JP; Liu BC
Proteomics Clin Appl; 2007 May; 1(5):476-85. PubMed ID: 21136699
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulomics : a serum autoantibody-based platform for transcription factor profiling.
Tassinari OW; Aponte M; Caiazzo RJ; Liu BC
Methods Mol Biol; 2008; 441():163-73. PubMed ID: 18370318
[TBL] [Abstract][Full Text] [Related]
8. Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays.
Gunawardana CG; Memari N; Diamandis EP
Clin Biochem; 2009 Mar; 42(4-5):426-9. PubMed ID: 19094976
[TBL] [Abstract][Full Text] [Related]
9. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers.
Miller JC; Zhou H; Kwekel J; Cavallo R; Burke J; Butler EB; Teh BS; Haab BB
Proteomics; 2003 Jan; 3(1):56-63. PubMed ID: 12548634
[TBL] [Abstract][Full Text] [Related]
10. A novel antibody microarray format using non-covalent antibody immobilization with chemiluminescent detection.
Usui-Aoki K; Shimada K; Koga H
Mol Biosyst; 2007 Jan; 3(1):36-42. PubMed ID: 17216054
[TBL] [Abstract][Full Text] [Related]
11. Multiplexed protein analysis using spotted antibody microarrays.
Haab BB; Zhou H
Methods Mol Biol; 2004; 264():33-45. PubMed ID: 15020778
[TBL] [Abstract][Full Text] [Related]
12. Antibody microarrays for native toxin detection.
Rucker VC; Havenstrite KL; Herr AE
Anal Biochem; 2005 Apr; 339(2):262-70. PubMed ID: 15797567
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer.
Tang L; Yang J; Ng SK; Rodriguez N; Choi PW; Vitonis A; Wang K; McLachlan GJ; Caiazzo RJ; Liu BC; Welch WR; Cramer DW; Berkowitz RS; Ng SW
Eur J Cancer; 2010 Jan; 46(1):170-9. PubMed ID: 19926475
[TBL] [Abstract][Full Text] [Related]
14. A cancer protein microarray platform using antibody fragments and its clinical applications.
Song S; Li B; Wang L; Wu H; Hu J; Li M; Fan C
Mol Biosyst; 2007 Feb; 3(2):151-8. PubMed ID: 17245494
[TBL] [Abstract][Full Text] [Related]
15. Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.
Draghici S; Chatterjee M; Tainsky MA
Expert Rev Mol Diagn; 2005 Sep; 5(5):735-43. PubMed ID: 16149876
[TBL] [Abstract][Full Text] [Related]
16. Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies.
Chruscinski A; Huang FY; Ulndreaj A; Chua C; Fehlings M; Rao V; Ross HJ; Levy GA
J Vis Exp; 2016 Sep; (115):. PubMed ID: 27685156
[TBL] [Abstract][Full Text] [Related]
17. Optimization of a microarray sandwich-ELISA against hINF-gamma on a modified nitrocellulose membrane.
Reck M; Stahl F; Walter JG; Hollas M; Melzner D; Scheper T
Biotechnol Prog; 2007; 23(6):1498-505. PubMed ID: 17894469
[TBL] [Abstract][Full Text] [Related]
18. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays.
Chen S; LaRoche T; Hamelinck D; Bergsma D; Brenner D; Simeone D; Brand RE; Haab BB
Nat Methods; 2007 May; 4(5):437-44. PubMed ID: 17417647
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients.
Kalniņa Z; Siliņa K; Meistere I; Zayakin P; Rivosh A; Abols A; Leja M; Minenkova O; Schadendorf D; Linē A
J Immunol Methods; 2008 May; 334(1-2):37-50. PubMed ID: 18314130
[TBL] [Abstract][Full Text] [Related]
20. Exploring cDNA phage display for autoantibody profiling in the serum of multiple sclerosis patients: optimization of the selection procedure.
Govarts C; Somers K; Hupperts R; Stinissen P; Somers V
Ann N Y Acad Sci; 2007 Aug; 1109():372-84. PubMed ID: 17785326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
